Posted in M&A / Deals EverSea Medicines to acquire Hasten Biopharmaceuticals April 9, 2026 Pharmaceutical Business Review The acquisition aims to enhance Everest Medicines’ presence and commercial capabilities across key regional markets. M&A / DealsRead full story